Avon Lifesciences has informed about the investor grievance report of the company for the Quarter ended 30th June, 2017 in terms of Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
The above information is a part of company’s filings submitted to BSE.